03/08/2024
6:57 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:58 PM | iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:00 PM | Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:01 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
7:00 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2024
7:01 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:09 AM | iTeos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/06/2024
6:19 AM | iTeos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/16/2024
11:54 AM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
8:45 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024
4:00 PM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
3:26 PM | iTeos Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
12/07/2023
7:20 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:21 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:22 PM | Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:22 PM | iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:16 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/07/2023
7:17 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
6:06 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2023
3:12 PM | iTeos Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/12/2023
4:09 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
8:28 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
8:35 PM | Boxer Capital, LLC (Reporting)
iTeos Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023
6:02 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/26/2023
6:53 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
6:04 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
6:52 PM | Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:53 PM | DiRocco Derek (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:54 PM | Hallal David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:55 PM | Ho Tony W (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:55 PM | Iannone Robert (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:56 PM | iTeos Therapeutics (Issuer)
RHOADS ANN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:57 PM | iTeos Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2023
11:15 PM | iTeos Therapeutics (Filer)
| Form EFFECT | |
05/10/2023
6:52 AM | iTeos Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/10/2023
6:09 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/27/2023
6:14 AM | iTeos Therapeutics (Filer)
| Form ARS | |
04/27/2023
6:05 AM | iTeos Therapeutics (Filer)
| Form DEF 14A | |
04/27/2023
6:09 AM | iTeos Therapeutics (Filer)
| Form DEFA14A | |
